A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Post-Conference Report Provides HIV Cure Roadmap
Life Expectancy With HIV Increases Dramatically
Improper Use of a Neti Pot Can Be Fatal
Animal Studies Suggest Anti-Reservoir Drugs May Help 'Functionally Cure' HIV
Tenofovir Microbicide Gel Falters in Major HIV Prevention Study
Gold Drug Shows HIV Eradication Potential
New Studies Under Way of Sangamo's Possible 'Functional Cure' Gene Therapy
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

December 22, 2008

Truvada, Viread and Emtriva Co-Pay Assistance Program Now Available

Gilead Sciences has launched a Truvada co-payment assistance program to help eligible people living with HIV reduce their out-of-pocket medication expenses. The program kicks in for insurance co-payments above $50 and covers up to $200 a month for Truvada (tenofovir plus emtricitabine), as well as Viread (tenofovir) and Emtriva (emtricitabine) if they are used separately.

HIV-positive people are eligible for the new Gilead program if they have out-of-pocket costs associated with insurance co-payments for their medications and their prescriptions are not covered by Medicaid, Medicare, a state AIDS Drug Assistance Program (ADAP) or other government-funded assistance program.

Because of its licensing agreement with Bristol-Myers Squibb, Gilead is unable to extend its co-payment assistance program to prescriptions for Atripla (efavirenz, tenofovir and emtricitabine). Additionally, Massachusetts residents are not eligible for the program.

Patients can enroll by obtaining a co-payment assistance card from their physicians or health care providers. If a health care provider does not have a card available, patients can call a toll-free number (888.358.0398) to enroll immediately and receive a card in the mail.

Search: Truvada, Viread, Emtriva, Atripla, co-payment, insurance, ADAP, Medicaid, Medicare, assistance


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 4 (of 4 total)    

Penny, , 2011-04-12 17:34:32
My copay is $75, so I plan on calling. The way the economy is going, I take all the help I can get.

egg, , 2009-01-09 09:03:51
This is not such a generous program [as well as these folks] because of the minimum 50.01 co pay requirement. You must have BAD insurance. People with good insurance need not apply. only after you are made to feel bad for having good insurance.

suresh Babu, Hyderabad, 2008-12-30 01:34:33
Please I want HIV cure medication Truvada medication available in Hyderabad city please tell me Address or any places tell me Address and phone numbers. Thanq sir.

David Warren, San Francisco, 2008-12-24 13:33:54
"The program kicks in for insurance co-payments above $50 and covers up to $200 a month for Truvada (tenofovir plus emtricitabine), as well as Viread (tenofovir) and Emtriva (emtricitabine) if they are used separately." Does this mean only co-payments associated with these specific meds or can the cumulative total of co-payments for all HIV meds in a patients regimen qualify for $50 and $200 thresholds?

comments 1 - 4 (of 4 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    FierceLittleGuy
    WEST HOLLYWOOD
    California


    MidwestMeetsNYC
    New York City
    New York


    jonjonhg
    nyc
    New York


    BLatinoGuy
    Fayetteville
    North Carolina
Click here to join POZ Personals!
Conference Coverage

6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


XVIII International AIDS Conference
Vienna, Austria
July 18-23, 2010

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.